Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Revanesse Shape + lidocaine
- Development stage
- Unknown
- Lead developer
- Prollenium Medical Technologies
- Modality
- Small Molecules
- Administration
- Subcutaneous, Intradermal, (specifically Injected Into Mid To Deep Dermis Or Subcutaneous Tissue)
01
Overview
**Revanesse Shape + lidocaine** is a cross-linked hyaluronic acid-based dermal filler combined with lidocaine and designed for injection into deep tissues of the face for cosmetic enhancement and correction of deep facial wrinkles, contouring, and volume restoration. The hyaluronic acid provides structural support and volume by attracting and retaining water in the tissues, while lidocaine is included for localized pain relief during the injection procedure. Typical application areas include cheeks, jawline, chin, nasolabial folds, marionette lines, and nose bridge. It is indicated for adult patients seeking aesthetic improvement of facial contours, deep wrinkles, and age-related volume loss, with effects lasting typically 6–12 months depending on treatment area and patient factors. The product is delivered as a transparent, colorless, sterile gel in pre-filled syringes and should be administered by qualified medical professionals[1][2][3][4][5][6].
- Brand names
- Revanesse Shape + lidocaine
- Other names
- Revanesse Shape+ Lidocaine
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Revanesse Shape + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Revanesse Shape + lidocaine.